Extracorporeal membrane oxygenation (ECMO), also known as extracorporeal life support (ECLS), is an extracorporeal technique of providing prolonged cardiac and respiratory support to persons whose heart and lungs are unable to provide an adequate amount of gas exchange or perfusion to sustain life. The technology for ECMO is largely derived from cardiopulmonary bypass, which provides shorter-term support with arrested native circulation. The device used is a membrane oxygenator, also known as an artificial lung. ECMO works by temporarily drawing blood from the body to allow artificial oxygenation of the red blood cells and removal of carbon dioxide. Generally, it is used either post-cardiopulmonary bypass or in late-stage treatment of a person with profound heart and/or lung failure, although it is now seeing use as a treatment for cardiac arrest in certain centers, allowing treatment of the underlying cause of arrest while circulation and oxygenation are supported. ECMO is also used to support patients with the acute viral pneumonia associated with COVID-19 in cases where artificial ventilation is not sufficient to sustain blood oxygenation levels.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Extracorporeal Membrane Oxygenators (ECMO) industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Infant Paediatric Oxygenators
Adult Oxygenators
Market Segment by Product Application
Respiratory
Cardiac
Extra-Corporeal Cardiopulmonary Resuscitation (ECPR)
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Getinge
Medtronic
LivaNova
Chalice Medical
MicroPort
NIPRO
XENIOS
OriGen Biomedical
EUROSETS S.r.l.
Braile Biom?dica
WEGO
Xijian Medical
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Extracorporeal Membrane Oxygenators (ECMO) consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Extracorporeal Membrane Oxygenators (ECMO) market by identifying its various subsegments.
3.Focuses on the key global Extracorporeal Membrane Oxygenators (ECMO) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Extracorporeal Membrane Oxygenators (ECMO) with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Extracorporeal Membrane Oxygenators (ECMO) submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Extracorporeal Membrane Oxygenators (ECMO) Market Research Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Extracorporeal Membrane Oxygenators (ECMO) Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Extracorporeal Membrane Oxygenators (ECMO) Segment by Type
2.1.1 Infant Paediatric Oxygenators
2.1.2 Adult Oxygenators
2.2 Market Analysis by Application
2.2.1 Respiratory
2.2.2 Cardiac
2.2.3 Extra-Corporeal Cardiopulmonary Resuscitation (ECPR)
2.2.4 Others
2.3 Global Extracorporeal Membrane Oxygenators (ECMO) Market Comparison by Regions (2016-2026)
2.3.1 Global Extracorporeal Membrane Oxygenators (ECMO) Market Size (2016-2026)
2.3.2 North America Extracorporeal Membrane Oxygenators (ECMO) Status and Prospect (2016-2026)
2.3.3 Europe Extracorporeal Membrane Oxygenators (ECMO) Status and Prospect (2016-2026)
2.3.4 China Extracorporeal Membrane Oxygenators (ECMO) Status and Prospect (2016-2026)
2.3.5 Japan Extracorporeal Membrane Oxygenators (ECMO) Status and Prospect (2016-2026)
2.3.6 Southeast Asia Extracorporeal Membrane Oxygenators (ECMO) Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Extracorporeal Membrane Oxygenators (ECMO) Industry Impact
2.5.1 Extracorporeal Membrane Oxygenators (ECMO) Business Impact Assessment - Covid-19
2.5.2 Market Trends and Extracorporeal Membrane Oxygenators (ECMO) Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Extracorporeal Membrane Oxygenators (ECMO) Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Extracorporeal Membrane Oxygenators (ECMO) Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Extracorporeal Membrane Oxygenators (ECMO) Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Extracorporeal Membrane Oxygenators (ECMO) Manufacturer Market Share
3.5 Top 10 Extracorporeal Membrane Oxygenators (ECMO) Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Extracorporeal Membrane Oxygenators (ECMO) Market
3.7 Key Manufacturers Extracorporeal Membrane Oxygenators (ECMO) Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Extracorporeal Membrane Oxygenators (ECMO) Industry Key Manufacturers
4.1 Getinge
4.1.1 Compan Detail
4.1.2 Getinge Extracorporeal Membrane Oxygenators (ECMO) Product Introduction, Application and Specification
4.1.3 Getinge 164 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Getinge News
4.2 Medtronic
4.2.1 Compan Detail
4.2.2 Medtronic Extracorporeal Membrane Oxygenators (ECMO) Product Introduction, Application and Specification
4.2.3 Medtronic Extracorporeal Membrane Oxygenators (ECMO) Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Getinge News
4.3 LivaNova
4.3.1 Compan Detail
4.3.2 LivaNova Extracorporeal Membrane Oxygenators (ECMO) Product Introduction, Application and Specification
4.3.3 LivaNova Extracorporeal Membrane Oxygenators (ECMO) Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 LivaNova News
4.4 Chalice Medical
4.4.1 Compan Detail
4.4.2 Chalice Medical Extracorporeal Membrane Oxygenators (ECMO) Product Introduction, Application and Specification
4.4.3 Chalice Medical Extracorporeal Membrane Oxygenators (ECMO) Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Chalice Medical News
4.5 MicroPort
4.5.1 Compan Detail
4.5.2 Chalice Medical Extracorporeal Membrane Oxygenators (ECMO) Product Introduction, Application and Specification
4.5.3 MicroPort Extracorporeal Membrane Oxygenators (ECMO) Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 MicroPort News
4.6 NIPRO
4.6.1 Compan Detail
4.6.2 NIPRO Extracorporeal Membrane Oxygenators (ECMO) Product Introduction, Application and Specification
4.6.3 NIPRO Extracorporeal Membrane Oxygenators (ECMO) Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 NIPRO News
4.7 XENIOS
4.7.1 Compan Detail
4.7.2 XENIOS Extracorporeal Membrane Oxygenators (ECMO) Product Introduction, Application and Specification
4.7.3 XENIOS Extracorporeal Membrane Oxygenators (ECMO) Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 OriGen Biomedical
4.8.1 Compan Detail
4.8.2 OriGen Biomedical Extracorporeal Membrane Oxygenators (ECMO) Product Introduction, Application and Specification
4.8.3 OriGen Biomedical Extracorporeal Membrane Oxygenators (ECMO) Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 OriGen Biomedical News
4.9 EUROSETS S.r.l.
4.9.1 Compan Detail
4.9.2 EUROSETS S.r.l. Extracorporeal Membrane Oxygenators (ECMO) Product Introduction, Application and Specification
4.9.3 EUROSETS S.r.l. Extracorporeal Membrane Oxygenators (ECMO) Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 EUROSETS S.r.l. News
4.10 Braile Biom
Getinge
Medtronic
LivaNova
Chalice Medical
MicroPort
NIPRO
XENIOS
OriGen Biomedical
EUROSETS S.r.l.
Braile Biom